Skip to main content
Clinical Trials/NCT04816448
NCT04816448
Completed
Not Applicable

Effects of Sub-Occipital Myofascial Release in Patients With Cervicogenic Headache

Riphah International University1 site in 1 country22 target enrollmentApril 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cervicogenic Headache
Sponsor
Riphah International University
Enrollment
22
Locations
1
Primary Endpoint
NECK DISABILITY INDEX
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Cervicogenic headache is a secondary form of headache that occurs from the upper cervical spine and atlanto-occipital joint. A CGH is a frequent source of chronic headache and is frequently misdiagnosed .Cervicogenic headache is among the most common problem affecting four times more women as compared to males and is considered by some painful feeling in the head , neck ,temporal area, frontal area and around the eyes areas.

Detailed Description

There is also pain in the face and ipsilateral head that does not alternate the sides, but when cervicogenic headache becomes severe, in some patients pain may occasionally feel it on the other side of the head. Diagnosis of cervicogenic headache depends on the detailed patient's history, manual examination and the assessment of nervous system. After the diagnostic block test disappearance of headache shows that the source of this pain is cervical spine. Cervical flexion rotation test is a very useful diagnostic measure in cervical movement restriction and differential diagnosis of cervicogenic headache. Physical therapy is considered most effective treatment of cervicogenic headache in which different techniques manipulative therapy, mobilization of cervical vertebrae, stretches and sub-occipital myofascial release used. Objective: To determine the effects of sub-occipital myofascial release in patients with cervicogenic headache. Methods: This study was randomized control trial and on the basis of inclusion criteria, 22 patients were included and were randomized through sealed envelope in two groups A and B. Group A was given sub-occipital myofascial release along with conventional therapy while group B was given cervical mobilization and conventional therapy and both groups were assessed by using Neck Disability Index(NDI), Pain Numerical Rating Scale(PNRS) and cervical range of motion by goniometer at baseline, Week(1-4) and 8th week( last week) .The data was analyzed using SPSS 21.

Registry
clinicaltrials.gov
Start Date
April 1, 2020
End Date
December 30, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • • Both Genders
  • Age between 20 to 75 Years
  • Neck pain referring the unilateral pain to the sub-occipital region and head.
  • Headache intensifying upon manual pressure to upper cervical joints and muscles
  • With the cranio-cervical Flexion rotation exam, neck pain and ipsilateral headache and restriction of C1 and C2 rotation.

Exclusion Criteria

  • • Tension headache (Headache on both sides)
  • If the patient not tolerate the cranio-cervical Flexion rotation test.
  • Patients presents with autonomic symptoms like visual disturbance, vertigo, dizziness.
  • If the physiotherapeutic modalities used for head pain in the last 6 months.
  • Headache other than cervical origins.
  • Clinically diagnosed as case of cervical radiculopathy or myelopathy.
  • Extreme cervical discomfort due to disk herniation, stenosis of the spinal canal and cervical arthritis.
  • Each other disorder that may be contraindicated in the upper cervical area of myofascial release.

Outcomes

Primary Outcomes

NECK DISABILITY INDEX

Time Frame: 4 months

the overall score range is between 0 and 50, 0 being no to little pain and discomfort while 50 being the severest degree of pain and disability with complete activity limitation.

Pain Numeric Rating Scale

Time Frame: 4 months

Pain Numeric Rating Scale (PNRS) scores in subjects with moderate/severe pain at baseline. \*P \< 0.0001 vs. baseline. Includes only subjects with baseline PNRS score of 4 to 10. Scale ranges from 0 to 10.

Study Sites (1)

Loading locations...

Similar Trials